Share management insights, impart management experience, and the chairman will teach the reserve management talents.
Release time:
2022-11-01
participated in this training, in addition to the reserve management talents of "Flying Eagle" and "Young Eagle" selected in previous times, there were also heads of functional departments of the group headquarters and management backbones of subordinate enterprises. In the training, Jiang Xiaomeng started from the understanding of the essence of the enterprise, combined with his daily learning of economics, management knowledge and practical work experience, elaborated on the business elements, the strategic level of the enterprise and the qualities that managers must possess. He pointed out that to be an excellent manager, one must have a strong sense of professionalism and a high sense of responsibility, have the courage and cautious attitude, have outstanding wisdom and the ability to be competent for leadership positions, and have Serious discipline, the quality of strict governance of the enterprise, fairness and integrity, and the character of clear rewards and punishments must have the spirit of brainstorming, trusting subordinates, caring for employees, and the style of close contact with employees, we should have the attitude of seeking truth from facts and the quality of being honest and honest, set an example by example, and be strict with ourselves. We should pay attention to learning, keep pace with the times, and constantly improve our own quality to adapt to the change.
After analyzing the characteristics of advantageous enterprises and the key elements of running enterprises, Jiang Xiaomeng especially emphasized"Fear of the law, obey the rules, and always introspect". He said, "Only with a heart of awe can you stop doing something." If people have a heart of awe, they will have a direction, code of conduct, and norms, and they will be able to consciously restrain themselves and not do things that are out of line. Therefore, it is the basic quality that every enterprise operator with taste and thought should have.
Chairman's experience sharing has aroused strong repercussions from reserve talents and management backbones. When talking about learning experience, some people said that corporate culture is the core of enterprise development, and talents are the driving force of enterprise development. Strengthening the training and selection of talents within the enterprise is an important work to enhance the cohesion and centripetal force of the enterprise. Combined with the learning content and the current depressed market environment, some employees said that in order to survive better under the conditions of fully competitive industry, we should strive to carry out management innovation and technological innovation, establish competitive advantage by constantly reducing costs, and constantly open up the market through marketing innovation, so as to inject new impetus into the further development of enterprises. (Reporter)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31